Bo Öberg
Plus aucun poste en cours
Profil
Bo Fredrik Öberg is the founder of Medivir AB, which was founded in 1988.
He was the Chairman of Medivir AB from 1988 to 1996.
Dr. Öberg's former jobs include Senior Director-Research & Development at Astra AB from 1978 to 1988, Director at Medivir AB from 2013 to 2014, Director at The International Society for Antiviral Research, Director at Beactica Therapeutics AB, Director at ClanoTech AB, Principal at Clean Chemicals Sweden AB, Principal at Accuro Immunology AB, and Principal at Bioagri SRL.
Anciens postes connus de Bo Öberg
| Sociétés | Poste | Fin |
|---|---|---|
| MEDIVIR AB | Directeur/Membre du Conseil | 08/05/2014 |
| MEDIVIR AB | Fondateur | - |
Astra AB
 Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden. | Corporate Officer/Principal | - |
The International Society for Antiviral Research
 The International Society for Antiviral Research Miscellaneous Commercial ServicesCommercial Services The International Society for Antiviral Research operates an institution for the sharing of scientific developments in antiviral medicines. The private company is based in Logan, UT. | Directeur/Membre du Conseil | - |
Accuro Immunology AB
 Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MEDIVIR AB | Health Technology |
| Entreprise privées | 7 |
|---|---|
Astra AB
Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden. | Health Technology |
Clean Chemicals Sweden AB
 Clean Chemicals Sweden AB Pharmaceuticals: MajorHealth Technology Part of Kiilto Family Oy, Clean Chemicals Sweden AB is a pharmaceutical company based in Borlänge, Sweden. Clean Chemicals Sweden was acquired by Segulah Advisor AB from C.B. Fleet Co., Inc. on May 11, 2011. | Health Technology |
Accuro Immunology AB
Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Health Technology |
| Bioagri SRL | |
The International Society for Antiviral Research
The International Society for Antiviral Research Miscellaneous Commercial ServicesCommercial Services The International Society for Antiviral Research operates an institution for the sharing of scientific developments in antiviral medicines. The private company is based in Logan, UT. | Commercial Services |
Beactica Therapeutics AB
 Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Distribution Services |
ClanoTech AB
 ClanoTech AB Pharmaceuticals: MajorHealth Technology ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells. Its Alpha5beta1-integrin is strongly up-regulated in fibroblast when switching to the fibrotic state and in scars after glaucoma surgery. Its strategy spans from therapeutic areas with high commercial potential as wet Age Regulated Macular Degeneration to ophthalmology niche indications with orphan drug opportunity such as developing advent in glaucoma surgery techniques. The company was founded by Yihai Cao in 2006 and is headquartered in Solna, Sweden. | Health Technology |